Search clinical trials for: BioChaperone® Combo 75/25 at 0.8 U/kg

Total 7 results

Adocia

Completed

A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Adocia
Eli Lilly and Company

Completed

An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

Healthy

Germany
Hospices Civils de Lyon

Completed

Cystic Fibrosis Related Diabetes Screening. (D2M)

Cystic Fibrosis-related Diabetes
Northwestern University

Completed

The Effect of Intraoperative Esmolol to Improve Postoperative Quality of Recovery and Pain After Ambulatory Surgery

Pain

United States
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Karolinska Institutet

Terminated

Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture (GDHT)

Femoral Fracture

Sweden
Assistance Publique - Hôpitaux de Paris
Novartis

Completed

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome (MSN)

Nephrotic Syndrome

France

3

Subscribe